Topic: cardiac monitoring
The FDA approved Bayer’s Gadavist MRI contrast agent to help gauge the blood supply of the heart muscle.
Abbott’s new, smarter version of its implantable monitor for detecting irregular heartbeats now reduces the rate of false detection by 97%.
The FDA cleared a new device manager platform from Medtronic that allows physicians to program compatible cardiac implants using an iPad.
Bardy Diagnostics, developers of a remote cardiac monitoring chest patch, raised $35.5 million to help fund its platform and expand its sales force.
Ochsner Health System tapped Geneva Health Solutions to manage data collection and remote monitoring of its patients with implanted cardiac devices.
The FDA granted a 510(k) clearance to Retia Medical’s hemodynamic monitoring device for measuring a patient’s cardiac output in the ICU or OR.
The new Apple Watch’s electrocardiogram capability has gone live, available as a free software update that allows for wrist-based ECGs on the go.
The device is designed to enable the remote monitoring of heart failure patients and thereby improve outcomes.
ERT has snatched up iCardiac Technologies, which pioneered precision QT studies in early-phase clinical research.
The FDA has cleared Abbott’s smartphone-compatible ICM, which facilitates the remote monitoring of patients with arrhythmias.